Home > Animal Health & Nutrition > Veterinary Medical Devices > Bovine Tuberculosis Diagnosis Market

Bovine Tuberculosis Diagnosis Market Trends

Report ID: GMI12141
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Bovine Tuberculosis Diagnosis Market Trends

The growing prevalence of bovine tuberculosis is significantly driving the expansion of the market. As the incidence of this infectious disease rises, demand for advanced diagnostic solutions to effectively manage and control bovine tuberculosis in livestock has increased.

For instance, according to a statistics release by the Department for Environment, Food and Rural Affairs (Defra), there were 618 new herd incidents of bovine tuberculosis in Wales in the 12 months leading up to December 2023. This represents a 2.8% increase compared to the previous 12-month period, which recorded 601 new incidents. These statistics are categorized by Wales' designated TB areas, reflecting ongoing challenges in controlling the spread of bovine TB in the region. The increase highlights a persistent issue requiring continuous monitoring and management efforts.

Consequently, intensified monitoring and management initiatives are likely to drive advancements in diagnostic technologies and spur investment in testing and surveillance measures, thereby fuelling market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global bovine tuberculosis diagnosis industry was valued at USD 795.5 million in 2023 and is estimated to grow at a 7.5% CAGR from 2024 to 2032, driven by the rising global prevalence of bovine tuberculosis and advancements in diagnostic technologies.

The product segment dominated the global market and is anticipated to grow at a 7.4% CAGR over the forecast period due to its comprehensive range of diagnostic tools, including tuberculin skin tests, PCR assays, and ELISA kits.

The U.S. bovine tuberculosis diagnosis market accounted for the highest revenue in 2023 and is anticipated to grow at a 6.9% CAGR during the forecast period, driven by advancements in diagnostic technologies and enhanced surveillance methods.

Key players in the industry include Bio-Rad Laboratories, Chembio Diagnostics, Enfer, IDEXX Laboratories, IDVet, LIONEX, and PBD Biotech.